• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ATLN:VX

109.900 CHF 0.700 0.64%

As of 11:43:58 ET on 07/31/2014.

Company Profile for Actelion Ltd (ATLN)

Actelion Ltd. is a pharmaceutical company that develops and markets synthetic small-molecule drugs against diseases related to the endothelium. The Company's drugs, Veletri and Tracleer, are used in the treatment of heart and pulmonary conditions.

Contact Information

Actelion Ltd

Gewerbestrasse 16
Allschwil, 4123
Switzerland
Phone: 41-61-565-65-65
Fax: 41-61-565-65-00

Key Executives for Actelion Ltd (ATLN)

Jean-Paul ClozelCEO/Co-FounderAndre C MullerChief Financial Officer
Otto SchwarzExec VP/COOGuy BraunsteinExec VP/Head:Clinical Dev
Marian BorovskySenior VP/Secy/General CounselChristian AlbrichSenior VP/Head:Human Resources
Andrew C WeissSenior VP/Head:Investor RelationsPeter HerrmannVP/Head:Corporate Affrs/Compliance
Beat SteinerVP/Head:Drug Discovery BiologyThomas WellerVP/Head:Drug Discovery & Chem

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil